7th Annual Cardiovascular Disease Update

Release Date: November 2, 2015

Expiration Date: November 2, 2017

PROGRAM AGENDA

Renal Artery Sympathetic Denervation for Treatment Resistent Hypertension
Sahil A. Parikh, MD
Presenter reports no financial relationship relevant to this presentation. 

Shortness of Breath: Is it the heart or the lungs?
Robert Schilz, DO
Presenter reports no financial relationship relevant to this presentation. 

Cardiology and Cancer: Unintended LV Dysfunction and Heart Failure
Guilherme H. Oliveira, MD 
Presenter reports no financial relationship relevant to this presentation. 

New Antiplatelet and Anticoagulant Agents: Are you confused yet?
Daniel I. Simon, MD
Presenter reports no financial relationship relevant to this presentation. 

Complex Cardiac Surgery: What is Available for Your Patients in 2014?
Soon Park, MD

 

Sex, Drugs and Chest Pain
Gregory Stefano, MD
Presenter reports no financial relationship relevant to this presentation. 

Concluding Remarks
Alan Markowitz, MD

 

 Case Panel

Moderator:
Sri Krishna Madan Mohan, MD

Case 1: Aortic stenosis: TAVR vs. SAVR
Marco Costa, MD, PhD, Barry A. Effron, MD, and Alan H. Markowitz, MD

Case 2: HF Stage D: When is it time for more (CRT, VAD)
Chantal El-Amm, MD, Judith A. Mackall, MD, and Jose Ortiz, MD

Case 3: AF:Rate control-anticoagulation vs. ablation
Mauricio Arruda, MD and Judith A. Mackall, MD 

Case 4: DVT: LMWH-Coumadin vs. Rivaroxaban
Teresa L. Carman, MD and Barry A. Effron, MD

Media:

Recorded slides and audio presentation. Supplementary educational materials may include downloads of videos, print materials, slides or web pages.

To contact the CME Provider: 

Email CWRU CME at medcme@case.edu

Target Audience

This conference is intended to update practicing internists, family medicine physicians, primary care physicians, cardiologists, cardiac surgeons, vascular surgeons, endocrinologists, pulmonologists, physician assistants, nurse practitioners, nurses, residents and fellows on current topics in cardiovascular disease.

Global Needs Assessment/Goal Statement

Program content will focus on new information supported by the most recent scientific evidence that affects clinicians and their care of patients. Educational needs were identified from diverse sources, including data from University Hospitals physician panels, national clinical practice guidelines and patient care experiences relayed by past activity evaluations and requests from physicians. The intent is to educate viewers about new practices and treatments in one program by providing sufficient information about the physiology of the various disease states discussed, presenting new agents available to help their patients, and providing actionable guidelines to streamline their ability to assess patients and implement these practices. Presenters may also discuss any insurance or reimbursement issues that the practitioner and their patient can expect when implementing these new therapies.

Learning Objectives

After participating in the activity, participants will be able to:

Resistant Hypertension
- Review the pathophysiology of severe hypertension
- Gain an understanding of the epidemiology and prevalence of resistant hypertension
- Learn about pharmacologic and new device therapies for resistant hypertension

Shortness of Breath: Is it the heart or the lungs?
- Review the pathophysiology of dyspnea
- Learn a sound approach to the diagnostic evaluation of dyspnea - Know the cardiac and pulmonary causes of dyspnea

Cardiology and Cancer: Iatrogenic/Unintended LV Dysfunction and Heart Failure
- Gain an understanding of the emerging problem of cancer- related LV dysfunction and heart failure
- Learn the impact of chest radiation on coronary heart disease
- Discuss the importance of tyrosine-kinase inhibitors in cancer and their impact on cardiovascular disease

New Antiplatelet and Anticoagulant Agents: Are you confused yet?
- Review the pathophysiology of acute coronary syndromes, DVT/PE and AF
- Gain an understanding of the clinical trials of new antiplatelet and anticoagulant agents
- Learn an evidence-based approach for the initiation of new antiplatelet and anticoagulant agents

Complex Aortic Disease (TEVAR, EVAR)
- Review the pathophysiology of aortic aneurysms and dissection
- Gain an understanding of the indications for open surgical repair versus endovascular-based therapies
- Learn the complications and follow-up specific to EVAR for the treatment of AAA

Sex, Drugs and Chest Pain
- Review the pathophysiology of erectile dysfunction
- Gain an understanding of the pharmacologic and nonpharmacologic approaches for the treatment of ED
- Learn the complications of cocaine related to cardiovascular disease

Case Panel
- Learn an evidence-based approach to the consideration of surgical AVR (SAVR) versus transcatheter AVR (TAVR)
- Review the pathophysiology of vitamin D deficiency and cardiovascular disease
- Gain an appreciation of pharmacologic alternatives for anticoagulation for AF and DVT/PE

Accreditation Statement



Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

Case Western Reserve University School of Medicine designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ for each presentation. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgments

An educational grant from Medtronic in support of this activity is gratefully acknowledged. Acceptance of funding in support of this activity does not constitute endorsement of any product or manufacturer.

References and Additional Information

• Device-based therapies for resistant hypertension. Curr Pharm Des 2013; 19 (13): 2401-8.
• New oral anticoagulants for atrial fibrillation. Circulation 2012; 126: 133-137.
• Cardiovascular effects of cocaine. Circulation 2010; 122:2558-2569.

Planning Committee

Daniel Simon, MD
Course Director
Director, University Hospitals Harrington Heart & Vascular Institute
Chief, Division of Cardiovascular Medicine
University Hospitals Case Medical Center
Herman K. Hellerstein Chair in Cardiovascular Research Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Simon has received honoraria from Cordis, Medtronic Vascular, Merck and Janssen, and the CME Program has determined there is no conflict of interest.

Vikram Kashyap, MD
Co-Director, University Hospitals Harrington Heart & Vascular Institute
Chief, Division of Vascular Surgery & Endovascular Therapy
University Hospitals Case Medical Center
Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Kashyap reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Conference Faculty

Mauricio Arruda, MD
Director, Electrophysiology Center
Director, Atrial Fibrillation Center
University Hospitals Harrington Heart & Vascular Institute
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Arruda reports no financial relationship with a commercial interest relevant to this activity.

Teresa Carman, MD
Director, Vascular Medicine
Medical Director, Center for Wound Care
University Hospitals Case Medical Center
Medical Director, Anticoagulation Monitoring Service
University Hospitals Harrington Heart & Vascular Institute
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Carman receives research funding from Protocol PI, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Marco Costa, MD, PhD
Director, Interventional Cardiovascular Center
Director, Research & Innovation Center
University Hospitals Harrington Heart & Vascular Institute
Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Costa has received honoraria or a consulting fee from Abbott, St. Jude, Boston Scientific, Scitech, Cordis, Sanofi, Lilly, Medtronic, Gilead and OrbusNeich, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Barry Effron, MD
Director, Evaluation & Prevention Center
University Hospitals Harrington Heart & Vascular Institute
Figgie Family Chair in Clinical Cardiovascular Excellence
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Effron reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Chantal El-Amm, MD
Division of Cardiovascular Medicine
University Hospitals Case Medical Center
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. El-Amm reports no financial relationship with a commercial interest relevant to this activity.

Vikram Kashyap, MD
Co-Director, University Hospitals Harrington Heart & Vascular Institute
Chief, Division of Vascular Surgery and Endovascular Therapy
University Hospitals Case Medical Center
Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Kashyap reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Judith Mackall, MD
Section Chief, Cardiac Electrophysiology
University Hospitals Case Medical Center
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Mackall has received honoraria from St. Jude Medical, and the CME Program has determined there is no conflict of interest.

Sri Krishna Madan Mohan, MD
Chief Quality Officer
University Hospitals Harrington Heart & Vascular Institute
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Mohan reports no financial relationship with a commercial interest relevant to this activity.

Alan Markowitz, MD
Chief Surgical Officer
University Hospitals Harrington Heart & Vascular Institute
Marcella “Dolly” Haugh Chair in Valvular Surgery
University Hospitals Case Medical Center
Assistant Clinical Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Markowitz reports no financial relationship with a commercial interest relevant to this activity.

Guilherme Oliveira, MD
Director, Advanced Heart Failure & Transplant Center
University Hospitals Harrington Heart & Vascular Institute
Associate Clinical Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Oliveira reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Jose Ortiz, MD
Chief, Cardiology Section
Louis Stokes Cleveland VA Medical Center
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Ortiz reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Sahil Parikh, MD
Director, Experimental Interventional Cardiology Laboratory
University Hospitals Case Medical Center
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Parikh has received research support and honoraria from Medtronic, Boston Scientific and St. Jude, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Robert Schilz, DO
Interim Chief, Division of Pulmonary, Critical Care and Sleep Medicine
University Hospitals Case Medical Center
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Schilz reports no financial relationship with a commercial interest relevant to this activity.

Daniel Simon, MD
Course Director
Director, University Hospitals Harrington Heart & Vascular Institute
Chief, Division of Cardiovascular Medicine
University Hospitals Case Medical Center
Herman K. Hellerstein Chair in Cardiovascular Research
Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Simon has received honoraria from Cordis, Medtronic Vascular, Merck and Janssen, and the CME Program has determined there is no conflict of interest.

Gregory Stefano, MD
Director, Harrington Heart & Vascular Institute at University Hospitals Geauga Medical Center
Assistant Clinical Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Stefano reports no financial relationship with a commercial interest relevant to this activity

Disclosure Statement

The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve University School of Medicine CME Program also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.

Instructions

To receive a statement of credit for up to 0.5 AMA PRA Category 1 Credit(s)™ you must:
• Review the full content of the recorded session.
• Reflect on the content.
• Successfully complete the post-test. A score of 100% is required.
• Complete the evaluation.
• Print the certificate of credit for your records.
• Your credit will be recorded by the Case School of Medicine CME Program and made a part of your cumulative transcript.

Estimated Time to Complete this Educational Activity 

Including review of the supplementary material and completion of the post-test, this activity is expected to take 30 minutes to complete.

Fee

There is no fee for this program.

Medical Disclaimer

Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The author has checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
Although every effort is made to ensure that this material is accurate and up-to-date, it is provided for the convenience of the user and should not be considered definitive. Neither the author nor the Case Western Reserve University School of Medicine nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.
Learners are encouraged to confirm the information contained herein with other sources. This information should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians. The Case Western Reserve University School of Medicine will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising here from.

CME Program Privacy Policy

It is the policy of the Case Western Reserve University School of Medicine CME Program to maintain the privacy of patients’ Protected Health Information (PHI) and to abide by all state and federal privacy laws (including the Health Insurance Portability and Accountability Act of 1996 (HIPAA)).
Of specific concern to CME providers are situations where PHI might appear in a presenter’s written educational materials or audio/visual materials. For example, information attributable to a specific patient might be included in a written case study or verbal discussion of a case or might appear in a visual presentation such an x-ray or similar diagnostic image or test where patient identifiers have not been removed.
Accordingly, PHI may not be present in any aspect of an educational presentation without a patient’s written authorization (and such authorization must be HIPAA compliant after April 14, 2003).
Prior to presenting a presenter must represent and warrant that he/she has HIPAA-compliant authorization for any PHI in the presentation or presentation materials or that he/she acquired such protected health information from a source that (a) obtained a HIPAA-compliant authorization which authorizes Presenter's use of PHI during the presentation; or (b) was not under a legal obligation to maintain the patient's confidentiality.

CME Program Confidentiality Policy

It is the intent of the Case Western Reserve University CME Program in conformance with University policies to prevent identity theft to maintain the confidentiality of any physician or healthcare provider information obtained or utilized by the CME Program in the course of registration for CME activities, participation as faculty, preparation and release of transcripts of activities for which credit has been earned, or any other CME Program function that involves confidential information. Such confidential information includes physician mailing address, last four digits only of the Social Security number (used as a unique identifier) and record of credit hours earned.
All such confidential information will be (1) retained in a secure, password-protected electronic data base and filing system, (2) never displayed where it may be observed or recorded and (3) released individually only upon receipt of written authorization from the party requesting their own information.
The sole exception to the above is the use of the last four digits of the Social Security number in printed class lists to assure that participants with identical names are able to appropriately register or sign in.

Software Requirements

Flash Player Plugin
Adobe Acrobat Reader
Internet Explorer 5.5 or greater
Netscape 7.02 or greater
Safari and Firefox 1.5 or greater
Windows 98 SE or above
Mac OS X 10.2 or above
© 2014 University Hospitals

 

 

 

 

 

7th Annual Update on Vascular Disease